Pharmaceuticals & Life Sciences · Pharmaceutical Supply Chain

Serialization, Track & Trace Compliance

Enhances→Stable

Available Now

Production-ready. Commercial solutions exist and organizations are actively deploying.

Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.

What You Do Today

Implement and maintain drug serialization systems per DSCSA (US), FMD (EU), and other global track-and-trace requirements. Manage unique product identifiers, aggregation hierarchies, and verification systems across the supply chain from manufacturing through dispensing.

AI Technologies

Serialization Data AnalyticsException Management AICounterfeit Detection MLSupply Chain Visibility Platforms

Roles Involved

Who works on this

Digital Transformation LeaderOperating Model DesignerSupply Chain ManagerProcurement SpecialistProject Manager

VP/SVPDirectorManager/SupervisorCross-Functional

How It Works

AI analyzes serialization data flows to detect exceptions — missing serial numbers, aggregation errors, verification failures — before they cause supply chain disruptions. ML models identify patterns consistent with counterfeit product introduction. Supply chain visibility platforms track product movement in real-time from factory to pharmacy.

What Changes

Serialization compliance monitoring becomes automated and real-time. Counterfeit detection improves as AI identifies anomalous product movement patterns across the supply chain.

What Stays the Same

Designing serialization architecture across complex global supply chains, managing the operational disruption of serialization implementation, and coordinating with trading partners on interoperability require deep supply chain and regulatory expertise.

Cross-Industry Concepts

traceability supply chain visibility regulatory compliance

Evidence & Sources

•FDA DSCSA implementation guidance
•EU FMD verification system data

Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.

Last reviewed: March 2026

What To Do Next

This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.

Establish Your Baseline

Know where you are before you move

Before adopting AI tools for serialization, track & trace compliance, document your current state in pharmaceutical supply chain.

•

Map your current process: Document how serialization, track & trace compliance works today — who does what, how long each step takes, and where the bottlenecks are. Use your ERP data to establish a factual baseline.

•

Identify the judgment calls: Designing serialization architecture across complex global supply chains, managing the operational disruption of serialization implementation, and coordinating with trading partners on interoperability require deep supply chain and regulatory expertise. — these are the boundaries AI won't cross. Know them before you start.

•

Check your data readiness: AI tools for pharmaceutical supply chain need clean, accessible data. Check whether your ERP has the historical data, integrations, and quality to support Serialization Data Analytics tools.

Without a baseline, you can't tell whether AI actually improved serialization, track & trace compliance or just changed who does it.

Define Your Measures

What to track and how to calculate it

inventory turns

How to calculate

Measure inventory turns for serialization, track & trace compliance before and after AI adoption. Pull from your ERP.

Why it matters

This is the most direct indicator of whether AI is adding value to pharmaceutical supply chain.

fill rate

How to calculate

Track fill rate using the same methodology you use today. Don't change how you measure just because you changed how you work.

Why it matters

Speed without quality is just faster mistakes. Measure both together.

When to check: Check after 30 days of consistent use, then quarterly.

The commitment: Give new tools at least 30 days before judging. The first week is always awkward.

What NOT to measure: Don't measure AI adoption rate as a goal. Measure outcomes. If the tool helps with serialization, track & trace compliance, people will use it.